IF

Ian Feiner

Founder & Peptide Researcher, Meridian Peptides

Ian Feiner is the founder of Meridian Peptides and an independent biohacker and peptide researcher. He writes Meridian's research library to summarize the published literature on research compounds in plain language — always framed for laboratory and research use only.

Editorial standards

Every article in the Meridian research library is written to a single standard: it summarizes what the published literature has explored, in plain language, and it cites its sources. Nothing is presented as medical advice, and every compound is described strictly for laboratory and research use — never with claims of human benefit, dosing, or treatment. Where the evidence is preclinical (as it is for most research peptides), we say so plainly.

Articles by Ian

BPC-157: A Plain-Language Overview of the ResearchJul 2026How to Read a Peptide Certificate of Analysis (CoA)Jun 2026Tesamorelin: A Research Literature OverviewJun 2026MOTS-c: An Overview of the Mitochondrial-Peptide ResearchJun 2026NAD+ in Research: A Plain-Language OverviewMay 2026Semax: What the Nootropic Peptide Research ExploresMay 2026Selank: A Plain-Language Research OverviewMay 2026Retatrutide: The Triple-Agonist Research StoryApr 2026Tirzepatide: A GIP/GLP-1 Research OverviewApr 2026Semaglutide and the GLP-1 Research LandscapeApr 2026CJC-1295 (No DAC): A Research OverviewMar 2026Ipamorelin: An Overview of the Research LiteratureMar 2026GHK-Cu: What the Copper-Peptide Research ExploresFeb 2026TB-500: A Plain-Language Overview of the ResearchFeb 2026